Bruker price target lowered to $38 from $40 at Citi

Citi lowered the firm’s price target on Bruker (BRKR) to $38 from $40 and keeps a Neutral rating on the shares after the company reported Q2 results and lowered FY25 guidance, citing weaker than expected end markets, soft demand in China, and tariffs. The firm’s estimates move lower following the guidance cut, the analyst noted.